Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 108 (3), 350-4

Serum Levels of interleukin-6 Are Not Elevated in Patients With Alzheimer's Disease

Affiliations

Serum Levels of interleukin-6 Are Not Elevated in Patients With Alzheimer's Disease

C M van Duijn et al. Neurosci Lett.

Abstract

Serum levels of interleukin-6 (IL-6) were determined in 97 patients with clinically diagnosed Alzheimer's disease and 79 age- and sex-matched control subject. Median serum levels of IL-6 did not differ significantly between Alzheimer patients (8.6 U/ml) and controls (8.2 U/ml). Median levels of serum IL-6 were similar for sporadic and familial patients. The concentration of IL-6 was not associated with the severity of the dementia or the duration of the disease since first symptoms. According to these observations there is no evidence for a significant elevation in serum IL-6 in Alzheimer's disease.

Similar articles

See all similar articles

Cited by 14 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback